TROG_2014_ASM-program

TROG 201426th ANNUAL SCIENTIFIC MEETING 24TROG 201425 26th ANNUAL SCIENTIFIC MEETINGFRIDAY 4th APRIL 20147.30 - 8.30am TROG 09.02 (CHISEL) Trial Management Committee D Ball8.00 - 8.30am TROG Consumer Advisory Group J Torony8.45 - 9.05am Health Economics Chair:R McDowall8.45amGetting the most from your health economics data:combining trial and other dataM Haas9.05 - 9.30am Skin Chair:R McDowall9.05am9.10am9.15am9.20am09.03 (MP3): A Phase II Efficacy Study of chemo-radiotherapyin PET stage II and III Merkel Cell Carcinoma ofthe Skin (Open)08.09 (RTN2): A randomised trial of post-operativeradiation therapy following wide excision of neurotropicmelanoma of the head and neck (Open)05.01 (POST): Post-operative concurrent chemoradiotherapyversus post-operative radiotherapy inhigh-risk cutaneous squamous cell carcinoma of thehead and neck (Open)02.01: Randomised clinical trial of surgery versussurgery plus adjuvant radiotherapy for regional controlin patients with completely resected macroscopic nodalmetastatic melanoma (Closed)M PoulsenM FooteS PorcedduB Burmeister9.30 - 10.05am CNS Chair:R McDowall9.30am9.35am9.55am11.02 (SCORAD III): A Randomised phase III study ofsingle fraction radiotherapy compared to multi-fractionradiotherapy in patients with metastatic spinal cordcompression (Open)08.05 (WBRT): Whole Brain Radiotherapy followinglocal treatment of intracranial metastases of melanoma– a randomised phase III trial (Open)06.01: Primary chemotherapy with Temozolomide vsradiotherapy in patients with low grade gliomas afterstratification for genetic 1p loss: a phase III study(Closed)T HoltG FogartyG Ryan10.05 - 10.25am Lung Chair:S Babington10.05am10.10am10.15am10.20am10.25 - 10.50am Morning Tea09.02 (CHISEL): A Randomised phase III trial of highlyconformal hypofractionated image guided (“stereotactic”)radiotherapy (hypoRT) versus conventionally fractionatedradiotherapy (conRT) for inoperable early stage Inon-small cell lung cancer (Open)11.03 (P_LUNG-GP): Randomised phase III trial ofhigh dose palliative radiotherapy (HDPRT) vsconcurrent chemotherapy plus HDPRT (C-HDPRT) in goodperformance status patient with locally advanced orsmall volume metastatic NSCLC - not suitable for radicalchemo-radiotherapy (Open)13.01 (SAFRON II): Stereotactic ablative fractionatedradiotherapy versus radiosurgery for oligometastaticneoplasia to the lung. A randomized Phase II trial(Approved for Development)SABR: Surgery or Stereotactic Ablative Body RadiotherapyFor Early Stage Peripheral Non-Small Cell Lung Cancer(NSCLC) in Patient’s Considered at Higher Risk of SurgicalResection (Approved for Development)D BallM LehmanD BallF Hegi-Johnson10.50 - 12.40pm Past Successes and Looking Forward Chair:S Porceddu10.50am A Year of Achievements J Torony10.55am TROG - Time to re-think its strategic direction and alliances S Porceddu11.15am Quality of Life Working Party Committee Feedback A Macann11.25amInternational Consortium for Health OutcomesMeasurement (ICHOM)I Roos11.35am Clinical Trial Management Workshop Report J Keller11.45am11.55amTechnical Research Workshop Report and ANZRadiation Research Network UpdateReview of the ACDS pilot - a national Dosimetry audit inthe Australian contextR OatesI Williams12.05pm New Technologies and Techniques Committee T Kron12.15pm TROG’s 25 Year History J Denham12.35pm12.40 - 1.00pm LunchASM 2015 AnnouncementMeeting Closure1.00 - 3.00pm TROG Scientific Committee Meeting(committee members only)J MartinB Burmeister